131 related articles for article (PubMed ID: 34455594)
1. Synergistic activation of thrombin and angiotensin II receptors revealed by bioluminescence resonance energy transfer.
Al Zamel I; Palakkott A; Ayoub MA
FEBS Lett; 2021 Oct; 595(20):2628-2637. PubMed ID: 34455594
[TBL] [Abstract][Full Text] [Related]
2. Interplay Between Angiotensin II Type 1 Receptor and Thrombin Receptor Revealed by Bioluminescence Resonance Energy Transfer Assay.
Zamel IA; Palakkott A; Ashraf A; Iratni R; Ayoub MA
Front Pharmacol; 2020; 11():1283. PubMed ID: 32973514
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II type 1 receptor variants alter endosomal receptor-β-arrestin complex stability and MAPK activation.
Cao Y; Kumar S; Namkung Y; Gagnon L; Cho A; Laporte SA
J Biol Chem; 2020 Sep; 295(38):13169-13180. PubMed ID: 32703898
[TBL] [Abstract][Full Text] [Related]
4. Positive Modulation of Angiotensin II Type 1 Receptor-Mediated Signaling by LVV-Hemorphin-7.
Ali A; Palakkott A; Ashraf A; Al Zamel I; Baby B; Vijayan R; Ayoub MA
Front Pharmacol; 2019; 10():1258. PubMed ID: 31708782
[TBL] [Abstract][Full Text] [Related]
5. BRET-based assay to monitor EGFR transactivation by the AT
O'Brien SL; Johnstone EKM; Devost D; Conroy J; Reichelt ME; Purdue BW; Ayoub MA; Kawai T; Inoue A; Eguchi S; Hébert TE; Pfleger KDG; Thomas WG
Biochem Pharmacol; 2018 Dec; 158():232-242. PubMed ID: 30347205
[TBL] [Abstract][Full Text] [Related]
6. Conformational biosensors reveal allosteric interactions between heterodimeric AT1 angiotensin and prostaglandin F2α receptors.
Sleno R; Devost D; Pétrin D; Zhang A; Bourque K; Shinjo Y; Aoki J; Inoue A; Hébert TE
J Biol Chem; 2017 Jul; 292(29):12139-12152. PubMed ID: 28584054
[TBL] [Abstract][Full Text] [Related]
7. Monitoring TRPC7 Conformational Changes by BRET Following GPCR Activation.
Pétigny C; Dumont AA; Giguère H; Collette A; Holleran BJ; Iftinca M; Altier C; Besserer-Offroy É; Auger-Messier M; Leduc R
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269644
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the thrombin/protease-activated receptor 1 axis by chemokine (C
Gao X; Cheng YH; Enten GA; DeSantis AJ; Gaponenko V; Majetschak M
J Biol Chem; 2020 Oct; 295(44):14893-14905. PubMed ID: 32839271
[TBL] [Abstract][Full Text] [Related]
9. Insights into the Interaction of LVV-Hemorphin-7 with Angiotensin II Type 1 Receptor.
Ali A; Johnstone EKM; Baby B; See HB; Song A; Rosengren KJ; Pfleger KDG; Ayoub MA; Vijayan R
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33379211
[TBL] [Abstract][Full Text] [Related]
10. Protease-activated receptor 1 (PAR1) and PAR4 heterodimers are required for PAR1-enhanced cleavage of PAR4 by α-thrombin.
Arachiche A; Mumaw MM; de la Fuente M; Nieman MT
J Biol Chem; 2013 Nov; 288(45):32553-32562. PubMed ID: 24097976
[TBL] [Abstract][Full Text] [Related]
11. Functional selectivity profiling of the angiotensin II type 1 receptor using pathway-wide BRET signaling sensors.
Namkung Y; LeGouill C; Kumar S; Cao Y; Teixeira LB; Lukasheva V; Giubilaro J; Simões SC; Longpré JM; Devost D; Hébert TE; Piñeyro G; Leduc R; Costa-Neto CM; Bouvier M; Laporte SA
Sci Signal; 2018 Dec; 11(559):. PubMed ID: 30514808
[TBL] [Abstract][Full Text] [Related]
12. Allosteric modulation of β-arrestin-biased angiotensin II type 1 receptor signaling by membrane stretch.
Tang W; Strachan RT; Lefkowitz RJ; Rockman HA
J Biol Chem; 2014 Oct; 289(41):28271-83. PubMed ID: 25170081
[TBL] [Abstract][Full Text] [Related]
13. Genetic code expansion and photocross-linking identify different β-arrestin binding modes to the angiotensin II type 1 receptor.
Gagnon L; Cao Y; Cho A; Sedki D; Huber T; Sakmar TP; Laporte SA
J Biol Chem; 2019 Nov; 294(46):17409-17420. PubMed ID: 31530642
[TBL] [Abstract][Full Text] [Related]
14. Direct GPCR-EGFR interaction enables synergistic membrane-to-nucleus information transfer.
Gekle M; Eckenstaler R; Braun H; Olgac A; Robaa D; Mildenberger S; Dubourg V; Schreier B; Sippl W; Benndorf R
Cell Mol Life Sci; 2024 Jun; 81(1):272. PubMed ID: 38900158
[TBL] [Abstract][Full Text] [Related]
15. Prolonged AT
Hermosilla T; Encina M; Morales D; Moreno C; Conejeros C; Alfaro-Valdés HM; Lagos-Meza F; Simon F; Altier C; Varela D
Sci Rep; 2017 Aug; 7(1):10131. PubMed ID: 28860469
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II cyclic analogs as tools to investigate AT
St-Pierre D; Cabana J; Holleran BJ; Besserer-Offroy É; Escher E; Guillemette G; Lavigne P; Leduc R
Biochem Pharmacol; 2018 Aug; 154():104-117. PubMed ID: 29684376
[TBL] [Abstract][Full Text] [Related]
17. Label-free cell signaling pathway deconvolution of angiotensin type 1 receptor reveals time-resolved G-protein activity and distinct AngII and AngIIIIV responses.
Lavenus S; Simard É; Besserer-Offroy É; Froehlich U; Leduc R; Grandbois M
Pharmacol Res; 2018 Oct; 136():108-120. PubMed ID: 29959993
[TBL] [Abstract][Full Text] [Related]
18. Quantifying biased signaling in GPCRs using BRET-based biosensors.
Namkung Y; Radresa O; Armando S; Devost D; Beautrait A; Le Gouill C; Laporte SA
Methods; 2016 Jan; 92():5-10. PubMed ID: 25890247
[TBL] [Abstract][Full Text] [Related]
19. Lack of evidence for AT1R/B2R heterodimerization in COS-7, HEK293, and NIH3T3 cells: how common is the AT1R/B2R heterodimer?
Hansen JL; Hansen JT; Speerschneider T; Lyngsø C; Erikstrup N; Burstein ES; Weiner DM; Walther T; Makita N; Iiri T; Merten N; Kostenis E; Sheikh SP
J Biol Chem; 2009 Jan; 284(3):1831-9. PubMed ID: 19017652
[TBL] [Abstract][Full Text] [Related]
20. Differential Contribution of Transmembrane Domains IV, V, VI, and VII to Human Angiotensin II Type 1 Receptor Homomer Formation.
Young BM; Nguyen E; Chedrawe MAJ; Rainey JK; Dupré DJ
J Biol Chem; 2017 Feb; 292(8):3341-3350. PubMed ID: 28096461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
